Insider Trading History of Quay Steven C

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Quay Steven C since 2006. This trader's CIK number is 1008227. At the time of last reporting, Quay Steven C was the President & CEO of Atossa Therapeutics, Inc.. (stock ticker symbol ATOS). Also see all insider trading activities at Atossa Therapeutics, Inc..

Note that in the past QUAY STEVEN C also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Atossa Therapeutics, Inc. (ATOS) by Quay Steven C

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ATOS 11,239 $9,890 0 $0 0 $0
2016 ATOS 80,000 $23,500 0 $0 0 $0
2013 ATOS 0 $0 7,265 $41,105 0 $0

Yearly summary of insider trading at Nastech Pharmaceutical Co Inc (NSTK) by Quay Steven C

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 NSTK 0 $0 34,630 $423,662 0 $0
2006 NSTK 0 $0 27,332 $434,993 2,667 $26,083


Insider trading activities at 2 companies by Quay Steven C:

1. Atossa Therapeutics, Inc. (ATOS)

2. Nastech Pharmaceutical Co Inc (NSTK)

Table 1. Insider trading of Atossa Therapeutics, Inc. (ATOS) by Quay Steven C

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-05-21 ATOS Buy 11,239 .88 9,890
2016-03-09 ATOS Buy 15,000 .37 5,550
2016-02-16 ATOS Buy 15,000 .53 7,950
2016-01-19 ATOS Buy 50,000 .20 10,000
2013-10-01 ATOS Sale 7,265 5.66 41,105

Table 2. Insider trading of Nastech Pharmaceutical Co Inc (NSTK) by Quay Steven C

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-09-27 NSTK Sale 5,200 13.57 70,564
2007-07-25 NSTK Sale 5,800 12.23 70,963
2007-06-07 NSTK Sale 6,400 11.05 70,720
2007-04-18 NSTK Sale 5,850 12.04 70,410
2007-02-27 NSTK Sale 6,130 11.50 70,519
2007-01-25 NSTK Sale 5,250 13.43 70,486
2006-11-15 NSTK Sale 3,620 19.56 70,818
2006-10-09 NSTK Sale 5,175 15.62 80,807
2006-08-08 NSTK Sale 5,820 13.88 80,764
2006-04-25 NSTK Sale 5,100 15.75 80,345
2006-04-11 NSTK Option Ex 2,667 9.78 26,083
2006-04-11 NSTK Sale 2,667 15.83 42,218
2006-03-16 NSTK Sale 4,950 16.17 80,041

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Quay Steven C (President & CEO of Atossa Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.